CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients

Abstract Cell- and antibody-based CD19-directed therapies have demonstrated great potential for treating B-cell non-Hodgkin lymphoma (B-NHL). However, all these approaches suffer from limited response rates and considerable toxicity. Until now, therapy decisions have been routinely based on histopat...

Descrición completa

Detalles Bibliográficos

Principais autores:	Dominik Sonanini, Johannes Schwenck, Simone Blaess, Julia Schmitt, Andreas Maurer, Walter Ehrlichmann, Malte Ritter, Julia Skokowa, Manfred Kneilling, Gundram Jung, Falko Fend, Simon Krost, Christian M. Seitz, Peter Lang, Gerald Reischl, Rupert Handgretinger, Christian la Fougère, Bernd J. Pichler
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2024-05-01
Series:	Biomarker Research
Assuntos:	CD19 Positron emission tomography Imaging biomarker Theranostics CAR-T cells Molecular imaging
Acceso en liña:	https://doi.org/10.1186/s40364-024-00595-9
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!